| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
UM-HMC-3A |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cell viability |
SRB assay |
0.10 µM |
HDMEC |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
p-STAT3 |
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
STAT3 |
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity |
Western Blot |
0.10 µM |
UM-HMC-1 |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
p-STAT3 |
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
STAT3 |
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of rhIL-6 |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
p-STAT3 |
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
STAT3 |
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on protein activity in presence of conditionend medium |
Western Blot |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
| Tocilizumab |
Influence on cancer stem cells |
Salisphere assay |
0.10 µM |
UM-HMC-3B |
Homo sapiens |
|
|
|
